SCHEMBL7072057

SCHEMBL7072057

CCOC(=O)C(Cc1ccccc1OCc1cnc2cc(C)cc(C)c2c1OC(C)C)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.38
FFAR1 O14842 3/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HIF1A Q16665 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
MAPT P10636 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069562 0.93 FFAR4 (0.40) FFAR4FFAR1PTGDR2
SCHEMBL7072054 0.85 PPARA (0.43) FFAR4FFAR1
SCHEMBL7072416 0.84 NUDT1 (0.36) FFAR4MAPTALDH1A1GAAHPGD
SCHEMBL7068783 0.82 ALDH1A1 (0.38) FFAR4MEN1KMT2AMAPTALDH1A1
SCHEMBL7070034 0.82 MRGPRX4 (0.39) FFAR4FFAR1THRB
SCHEMBL7066501 0.81 MAPT (0.43) MEN1KMT2ATDP1MAPTALDH1A1
SCHEMBL7068137 0.80 FFAR4 (0.36) FFAR4FFAR1PTGDR2
SCHEMBL7070148 0.78 MAPT (0.38) FFAR4FFAR1CYP1A2CYP2C9MEN1
SCHEMBL7069559 0.78 PPARA (0.53)
SCHEMBL7069935 0.78 FFAR4 (0.36) FFAR4FFAR1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA FFAR4 734/4885FFAR1 439/4885CYP1A2 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.